NRIP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.936040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.401400E-01
Normal-vs-Stage2
2.341800E-01
Normal-vs-Stage3
5.818200E-02
Normal-vs-Stage4
3.741400E-01
Stage1-vs-Stage2
9.257600E-01
Stage1-vs-Stage3
2.762000E-01
Stage1-vs-Stage4
6.599200E-01
Stage2-vs-Stage3
2.563200E-01
Stage2-vs-Stage4
7.299600E-01
Stage3-vs-Stage4
1.086160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.358560E-01
Normal-vs-AfricanAmerican
9.134400E-01
Normal-vs-Asian
9.891700E-02
Caucasian-vs-AfricanAmerican
2.544200E-01
Caucasian-vs-Asian
3.355400E-01
AfricanAmerican-vs-Asian
8.158500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.220000E-01
Normal-vs-Female
1.740360E-01
Male-vs-Female
8.766800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.239850E-01
Normal-vs-Age(41-60Yrs)
6.207600E-01
Normal-vs-Age(61-80Yrs)
8.314500E-02
Normal-vs-Age(81-100Yrs)
5.142100E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.930040E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.261600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.439800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.239310E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.387900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.909400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.804400E-02
Normal-vs-Daily Drinker
2.840400E-02
Normal-vs-Weekly Drinker
9.415700E-02
Normal-vs-Occasional Drinker
2.662600E-01
Normal-vs-Social Drinker
6.865400E-01
Non Drinker-vs-Daily Drinker
2.847600E-01
Non Drinker-vs-Weekly Drinker
8.754400E-01
Non Drinker-vs-Occasional Drinker
2.620000E-01
Non Drinker-vs-Social Drinker
8.390200E-02
Daily Drinker-vs-Weekly Drinker
4.843200E-01
Daily Drinker-vs-Occasional Drinker
6.230000E-02
Daily Drinker-vs-Social Drinker
1.309600E-02
Weekly Drinker-vs-Occasional Drinker
3.152400E-01
Weekly Drinker-vs-Social Drinker
1.005420E-01
Occasional Drinker-vs-Social Drinker
3.611800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.076600E-01
Normal-vs-Grade 2
9.944100E-03
Normal-vs-Grade 3
1.241750E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.497400E-01
Grade 1-vs-Grade 3
1.487020E-01
Grade 1-vs-Grade 4
1.076600E-01
Grade 2-vs-Grade 3
4.021400E-01
Grade 2-vs-Grade 4
9.944100E-03
Grade 3-vs-Grade 4
1.241750E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.109610E-01
Normal-vs-NonDiabetic
1.340210E-01
Diabetic-vs-NonDiabetic
5.570400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.350800E-01
Normal-vs-NoPancreatitis
1.376850E-01
Pancreatitis-vs-NoPancreatitis
8.758800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.277400E-01
Normal-vs-N1
1.988430E-01
N0-vs-N1
6.306400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.719800E-01
Normal-vs-TP53-NonMutant
1.632410E-01
TP53-Mutant-vs-TP53-NonMutant
4.444200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
